The present disclosure relates generally to arteriovenous fistulas (AVFs). Patients with end-stage renal disease undergoing hemodialysis (HD) often require a functional vascular access, which may include arteriovenous fistula (AVF), arteriovenous graft, or central venous catheter. AVFs are one example access type which provide for superior longevity and lower infection rate, resulting in improved patient survival and lower cost when compared to other types of access. Despite these attributes, more than a third of AVFs fail to mature. Limited blood flow at the time of fistula creation is one cause for AVF maturation failure.
Arteriovenous fistulas are made by connecting a vein to an artery. An AVF may have, for example, at least 600 cc/min of blood flow, and may be >6 mm wide. When the AVF is created, the flow within the vein immediately increases from ˜20-60 cc/min to ˜200 cc/min since it is a low-resistance circuit. In one scenario, the flow will gradually increase over the following few weeks to achieve >600 cc/min. However, because of this sudden initial increase in blood flow, and the turbulence created by it, the vein's wall usually adapts by trying to become thicker (neo-intimal hyperplasia). This will prevent the blood flow from increasing further in the AVF, which limits its use. Current solutions to fix this include repeated angioplasty (stretching with a balloon from the inside) of the AVF, which is a costly procedure with its own risks.
Surgical creation of AVFs with higher blood flow might help with increasing the maturation rate. However, surgeons are usually reluctant to create such AVFs because high uncontrollable blood flow rates may develop and result in complications such as, but not limited to, steal-syndrome, heart failure (HF), pulmonary hypertension and cephalic arch stenosis (CAS). Therefore, a need exists for arteriovenous fistulas which provide adequate blood flow while solving the problems associated with higher blood flow.
Provided herein are systems, methods, and devices for arteriovenous fistulas which can adjust the flow rate of blood through the fistula. By adjusting the diameter of the arteriovenous fistula, blood flow through the fistula is controlled which can reduce complications associated with high blood flow. For example, a device of this disclosure may be opened or expanded during hemodialysis so that blood flow is adequate to filter waste and complete the renal replacement therapy. An example device may be closed or contracted when hemodialysis is complete so that everyday blood flow does not reach levels associated with complications.
In some implementations, an arteriovenous fistula banding device is disclosed, the device including: a band including a first end and a second end, the band extending circumferentially around a central axis to define a central channel having a first diameter; a housing coupled to the first end of the band and defining a housing slot to accept the second end of the band, wherein the housing is disposed outside of the central channel; a screw disposed within the housing and including at least one thread disposed adjacent to or abutting the band; and an actuator coupled to the screw, wherein the actuator causes rotation of the screw which causes the second end of the band to move away from or towards the first end of the band such that the first diameter of the central channel changes.
In some implementations, a device, wherein the actuator is a magnet rotatably disposed within the housing. The magnet may be a diametrically magnetized magnet (e.g., a neodymium magnet).
In some implementations, a device, wherein the central channel is sized to surround an arteriovenous fistula, and wherein rotation of the screw to change the first diameter of the central channel changes an internal diameter of the arteriovenous fistula. In some implementations, the arteriovenous fistula is disposed within the central channel and the blood flow through the fistula is controllably manipulable by the device.
The device may include one or more of a variety of engageable structures to expand or contract the band around the arteriovenous fistula. Roller wheels, a pre-tensioned spring, or a spool may be used in some examples. In other implementations, a worm screw mechanism is used to engage with the band. In some implementations, the band further includes a plurality of teeth protruding from an outer side of the band, wherein the plurality of teeth is engageable with the at least one thread of the screw. In some implementations, the band further includes a plurality of slots extending through the band from an outer side to an inner side, wherein the plurality of slots is engageable with the at least one thread of the screw.
In some implementations, the flow through the arteriovenous fistula is monitored (e.g., during a dialysis procedure). A variety of standard flow sensors may be provided to gather flow data and transmit it to a control system or nearby device. In some implementations, a device is disclosed further including a flow sensor disposed adjacent to the central channel, the flow sensor configured to measure fluid flow through the central channel.
The size of the device and band can affect the pressure placed on the arteriovenous fistula as well as the flow therethrough. Additionally, the size and materials used contribute to the flexibility and possible geometry of the device. In some implementations, a device is disclosed, wherein the first diameter of the central channel is adjustable from 3 mm to 15 mm. In some implementations, a device, wherein a width of the band as measured in a direction parallel to the central axis is in a range from 5 mm to 10 mm. In some implementations, a device, wherein the device includes a flexible resin and wherein the device is 3D printed in a curved configuration such that the band is biased towards the curved configuration.
In some implementations, a device, wherein the housing further includes a magnet cover piece separably couplable to the housing to cover the magnet.
A mechanism for attaching the device within a patient is disclosed, wherein a surgeon may attach the device adjacent to the arteriovenous fistula. In some implementations, a device, further including a suture protrusion extending out from the housing in a direction transverse to the band, wherein the suture protrusion is disposed outside of the central channel.
Containing the device to a desired location is disclosed, including method of preventing unnecessary movement or implantation failure of the device. In some implementations, a device, wherein the housing further includes an outer band housing enveloping the band and the central channel wherein the second end of the band is contained within the outer band housing regardless of the first diameter of the central channel. In some implementations, a device, wherein the outer band housing includes a track engageable with a portion of the band such that the band follows the track as it extends or retracts to expand or contract the central channel. In some implementations, a device, wherein the second end of the band further includes a mechanical stop to define a maximum diameter of the central channel. In some implementations, a device, wherein the plurality of teeth extend only from a distal portion of the band such that a proximal portion of the band defines a minimum diameter of the central channel.
A motor may also be used as the actuator such that the device may include internal driving of the screw to expand or contract the band. In some implementations, a device, wherein the actuator is a motor with a shaft coupled to the screw.
In some implementations, a device, further including: a control system including: a flow sensor disposed adjacent to the central channel, the flow sensor configured to measure fluid flow through the central channel; and a controller configured to receive a measured fluid flow, compare the measured fluid flow to a predetermined fluid flow, and drive the actuator to adjust the first diameter of the central channel based on the predetermined fluid flow.
In other implementations, a system is disclosed, the system including: an arteriovenous fistula banding device, the device including: a band including a first end and a second end, the band extending circumferentially around a central axis to define a central channel having a first diameter; a housing coupled to the first end of the band and defining a housing slot to accept the second end of the band, wherein the housing is disposed outside of the central channel; a screw disposed within the housing and including at least one thread disposed adjacent to or abutting the band; and a magnet rotatably disposed within the housing coupled to the screw, wherein rotation of the screw causes the second end of the band to move away from or towards the first end of the band such that the first diameter of the central channel changes; and an external driver including: a driver magnet; and a handle coupled to the driver magnet wherein rotating the handle of the external driver rotates the driver magnet about a turning axis and causes the magnet of the arteriovenous fistula banding device to rotate.
To drive the magnet of the device, an external electromagnetic field may be applied by a mechanical or electromechanical device. In some implementations, a system is disclosed, wherein the arteriovenous fistula banding device is disposed internal to a patient such that an arteriovenous fistula is disposed inside the central channel, and wherein the external driver is disposed outside of the patient such that the driver magnet of the external driver aligns with the magnet of the arteriovenous fistula banding device.
In some implementations, a system, further including: a control system including: a flow sensor disposed adjacent to the central channel, the flow sensor configured to measure fluid flow through the central channel; and a controller configured to receive a measured fluid flow from the flow sensor, compare the measured fluid flow to a predetermined fluid flow, and drive the external driver to adjust the first diameter of the central channel to a second diameter based on the predetermined fluid flow. In some implementations, a system, wherein the control system forms a feedback loop to continuously adjust the first diameter of the central channel. In some implementations, a system, wherein the predetermined fluid flow may be changed by a remote controller, which is either the same as or different from the controller of the control system, based on a type of procedure to be performed. In some implementations, a system, wherein the first diameter of the central channel limits the fluid flow and a second diameter larger than the first diameter increases fluid flow during a hemodialysis procedure.
In other implementations, a method of controlling blood flow through an arteriovenous fistula is disclosed, the method including: providing an arteriovenous fistula banding device including a band extending circumferentially to define a central channel having a first diameter, a screw having at least one thread disposed adjacent to or abutting the band, and a magnet coupled to the screw, wherein the arteriovenous fistula is disposed within the central channel; rotating the magnet to cause rotation of the screw such that the at least one thread of the screw contacts a portion of the band to expand or contract the central channel to a second diameter; and expanding or contracting an inner diameter of the arteriovenous fistula such that a fluid flow rate through the arteriovenous fistula is increased or decreased.
In some implementations, a method, further including: measuring the fluid flow rate through the central channel via a flow sensor disposed adjacent to the central channel.
In some implementations, a method, further including: receiving, at a controller, a measured fluid flow rate; comparing the measured fluid flow rate to a predetermined fluid flow rate; and adjusting the first diameter of the central channel to a second diameter based on a difference between the measured fluid flow rate and the predetermined fluid flow rate.
In some implementations, a method, further including: expanding the first diameter of the central channel and the inner diameter of the arteriovenous fistula for a duration of a hemodialysis process; and contracting the first diameter of the central channel and the inner diameter of the arteriovenous fistula when the hemodialysis process is complete.
In some implementations, a method, wherein rotating the magnet and the screw is accomplished by an external driver having a driver magnet, the external driver disposed outside a patient's body and adjacent to the arteriovenous fistula banding device.
Additional advantages will be set forth in part in the description which follows or may be learned by practice. The advantages will be realized and attained by means of the elements and combinations particularly pointed out in the appended claims. It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive, as claimed.
Various objects, aspects, features, and advantages of the disclosure will become more apparent and better understood by referring to the detailed description taken in conjunction with the accompanying drawings, in which like reference characters identify corresponding elements throughout. In the drawings, like reference numbers generally indicate identical, functionally similar, and/or structurally similar elements.
Referring generally to the figures, systems for controlling blood flow through an arteriovenous fistula (AVF) are shown, according to various implementations. Patients with end-stage renal disease undergoing hemodialysis (HD) may require a functional vascular access, which may include arteriovenous fistula (AVF), arteriovenous graft, or central venous catheter. AVFs may be preferred because they have superior longevity, lower infection rate resulting in improved patient survival and lower cost when compared to other types of access.
AVFs are made by surgically connecting a vein to an artery. An AVF may have at least 600 cc/min of blood flow and may be >6 mm wide. When this is done, the flow within the vein immediately increases from ˜20-60 cc/min to ˜200 cc/min since it is a low-resistance circuit. In one scenario the flow with gradually increase over the following few weeks to achieve a goal of >600 cc/min. However, because of this sudden initial increase in blood flow, and the turbulence created by it, the vein's wall usually adapts by trying to become thicker (neo-intimal hyperplasia). This will prevent the blood flow from increasing further in the AVF, which limits its use. The devices, systems, and methods described herein help to solve this problem of limited use of AVFs.
The device 10 of
The first diameter of the central channel 112 is 10 mm. However, in other implementations, the first diameter may be in the range from 3 mm to 10 mm (e.g., 3 mm, 5 mm, 7 mm, 10 mm). As will be described further, the first diameter of the central channel 112 is adjustable from 3 mm to 10 mm. The band 102 is sized to allow for the changes in diameter. For example, a change from 3 mm to 10 mm requires a circumference change of roughly 22 mm, meaning that the band 102 must have at least 22 mm of “slack” beyond that surrounding the smaller diameter configuration.
The band 102 further includes a plurality of teeth 114 protruding from the outer band surface 110. The plurality of teeth 114 are disposed at a slight angle with respect to the direction of the width of the band 102, as seen in
The plurality of teeth 114 of the band 102 extend only from a distal portion of the band 102 (e.g., from the second end 106 to a point in between the first end 104 and the second end 106) such that a proximal portion of the band 102 (e.g., from the first end 104 to a point in between the first end 104 and the second end 106) includes no teeth 114. Because the proximal portion of the band 102 includes no teeth, the screw 140 is unable to engage with or pull that portion of the band 102. Thus, the proximal portion of the band 102 defines a minimum diameter of the central channel 112.
In some implementations, the band 102 further includes a mechanical stop on the second end 106 of the band 102 to define in maximum diameter of the central channel 112. In either case, including a mechanical means of limiting the diameter of the central channel 112 prevents disconnection of the band 102 from the housing 120 or squeezing the arteriovenous fistula too small. In some implementations, a physical switch or secondary magnet mechanism prevents free rotation of the magnet and thus maintains the band in a particular configuration until activated by an external magnet. These and other safety mechanisms may be implemented in a variety of implementations of the device 100.
The housing 120 includes a first side 122 and a second side 124 opposite and spaced apart from the first side 122. The first side 122 is coupled to the first end 104 of the band 102. The second side 124 of the housing 120 defines a main opening 126 which accepts the second end 106 of the band 102 after it wraps around the central channel 112. Thus, the housing 120 is disposed outside of and adjacent to the central channel 112. In some implementations, the housing 120 has a thickness of 2-5 mm.
The housing 120 further defines a main cavity 130 which extends from the main opening 126 on the second side 124 to the first side 122 of the housing. The first side 122 of the housing further defines a housing slot 128 (more clearly visible in
The housing 120 further includes a pair of suture protrusions 132 extending out from the first side 122 of the housing 120 in a direction transverse to the band 102. The suture protrusions 132 are disposed outside of the central channel 112. Each of the suture protrusions 132 defines a suture hole 134 configured to accept a surgical suture (e.g., for implanting the device 100).
The screw 140 (e.g., a worm gear) is disposed within the main cavity 130 of the housing 120 such that the main opening 126 accepts the screw 140 into the main cavity 130. The screw 140 includes at least one thread 142 wrapped around the screw 140. The at least one thread 142 is disposed adjacent to or abutting the band 102 when the second end 106 of the band 102 enters the main cavity 130 though the main opening 126. Specifically, the plurality of teeth 114 of the band 102 are engageable with the at least one thread 142 of the screw 140. The screw 140 includes a first end 144 adjacent to the first side 122 of the housing and a second end 146 adjacent to the second side 124 of the housing 120.
The actuator 150 is coupled to the screw 140 (e.g., via adhesive resin or integrally formed together). Specifically, the actuator 150 is coupled to and/or disposed on the second end 146 of the screw 140. The actuator 150 in device 100 is disposed entirely outside of the main cavity 130 of the band 102. However, in other implementations, the actuator 150 may be partially disposed within the main opening 126.
The actuator 150 of device 100 is a magnet 150 (e.g., a diametrically-magnetized magnet) rotatably disposed adjacent to the main opening 126 of the housing 120. The magnet 150 and screw 140 are configured to rotate about a screw axis 155. However, in other implementations, the actuator is a motor with a shaft coupled to the screw. In some implementations, the motor actuator may further include an encoder, internal battery, and a transmission means (e.g., a Bluetooth antenna) to communicate with a remote controller. The motor may be, for example, a Micromo 3 mm diameter motor with a length of 8 mm.
Each device 100 and device 200 may be 3D printed in a curved configuration such that the band 102 or band 202 is biased towards the curved configuration. The devices described herein may also be printed in a flat configuration and then manipulated into a curved configuration as shown. In other implementations, the devices described herein are manufactured in a mold (e.g., a two-sided resin mold). The device 100 and device 200 may comprise a flexible resin (e.g., Flexible 80A resin), silicone, PTFE, or any other biocompatible material. In some implementations, the band comprises Flexible 80A resin.
In use, the device 100 is implanted within a patient (e.g., implanted in the arm of a patient adjacent to an arteriovenous fistula site). The device 100 may be secured in place by sutures engaging with the device 100 via the suture holes 134 of the suture protrusions 132. The screw 140 and magnet 150 are inserted through the main opening 126 of the housing 120. The screw 140 is rotatably disposed in the main cavity 130 while the magnet 150 is disposed outside of the housing 120 and attached to the screw 140.
The second end 106 of the band 102 is wrapped around a portion of the arteriovenous fistula until it reaches the second side 124 of the housing 120, thus defining the central channel 112 with the arteriovenous fistula disposed therein. The second end 106 of the band 102 is inserted through the main opening 126 and into the main cavity 130 adjacent to the screw 140. The plurality of teeth 114 on the outer band surface 110 of the band 102 abut and engage with the at least one thread 142 of the screw 140. The screw 140 with the magnet 150 may be rotated slightly to accept and secure the second end 106 of the band 102 within the main cavity 130. Then, the magnet cover piece 152 is secured to the housing 120 over the magnet 150.
When actuated, magnet 150 rotates about the screw axis 155 and causes rotation of the screw 140 about the screw axis 155 as well. Rotation of the screw 140 causes the at least one thread 142 to engage with the plurality of teeth 114 of the band 102. As the screw 140 and the at least one thread 142 rotates in a first direction (e.g., clockwise), the second end 106 of the band 102 moves further into the main cavity 130 of the housing 120 from the second side 124 to the first side 122. The second end 106 of the band 102 can exit the main cavity 130 through the housing slot 128 defined by the first side 122 of the housing 120. As the screw 140 rotates in the first direction and moves the band 102 through the housing 120, the diameter of the central channel 112 reduces. Thus, once the second end 106 of the band 102 exits the housing 120 via the housing slot 128, the second end 106 of the band moves away from the first end 104 of the band 102, thus reducing the diameter of the central channel 112. For the description of device 100, the first diameter will be the contracted configuration with the smaller diameter, shown in
When actuated to move in a second direction (e.g., counter-clockwise), the magnet 150 causes the screw 140 to rotate to expand the diameter of the central channel 112. The second end 106 of the band 102 moves towards the first end 104 of the band 102 and back through the housing slot 128 and into the main cavity 130 until a desired second diameter is reached.
The device 100 may be implanted in a patient and placed in the contracted configuration (first diameter of the central channel 112) as shown in
Once a patient is ready to undergo hemodialysis, the device 100 is moved from the contracted configuration to the expanded configuration of
Example Device and Control System
Control system 301 further includes a controller 370 configured to receive measured fluid flow data from the flow sensor 360. For example, the flow sensor 360 may transmit measured fluid flow data to the controller 370 remotely or by wired connection. The controller 370 may be disposed within the housing 120 of the device 300, or the controller 370 may be disposed within an external device nearby the patient and the device 300. The location or implementation of the controller 370 may depend on the procedure to be performed.
The controller 370 is configured to compare the measured fluid flow to a predetermined fluid flow (e.g., a desired blood flow stored in a memory on the controller). The controller 370 uses the comparison to drive the actuator or magnet 150, which turns the screw (e.g., screw 140) to adjust the band 102 and thus the diameter of the central channel 112. This process may be continuous (e.g., for the duration of a dialysis treatment) or discrete (e.g., set points throughout a dialysis treatment). The feedback loop formed between the device 300, the flow sensor 360, the controller 370, and the actuator 150 allows for accurate and fast control of blood flow through the arteriovenous fistula.
Alternative Embodiments
Example System Functionality
The following systems, devices, and examples describe and depict interconnected devices which depict the geometry and placement of various components. Two devices are often shown where the band of one device enters the housing of another to interact with the screw. While a two-device implementation is possible, these models primarily are provided to show the specific interaction and the interface between the plurality of teeth of the band with the screw.
Example Benchtop Prototype
An experiment was performed where the external magnet 780 was rotated about its axis nearby the device 700 with the axis of the magnet 750 (e.g., screw axis 155) substantially aligned with the axis of the external magnet 780. The experiment provided for human manipulation and rotation of the external magnet 780 as a proof of concept. Each of the magnet 750 and the external magnet 780 are diametrically-magnetized magnets (i.e., the poles of the magnet oppose each other along the width of the magnet, rather than along the axis of the magnet). Because they are diametrically-magnetized, rotation of the external magnet 780 can drive rotation of the magnet 750 when they are axially aligned. The results of the experiment showed that rotation of the external magnet 780 did cause a rotation of the magnet 750 which, in turn, caused a rotation of the screw 740. Therefore, the band 702 was pulled into the housing 720 and the diameter of the central channel 712 was reduced.
Variations on the distance between the magnets, the size of the magnets, and the materials used in the device 700 can yield various values of torque output. In some implementations, the magnets are sized such that a desired input torque drives rotation of the magnet 750 and screw 740 at a desired output torque.
External Driving System #1
Once an arteriovenous fistula banding device (e.g., device 100) is implanted in a patient, a need arises to reliably and controllable drive the actuator 150 (e.g., magnet 150). While some implementations of the device 100 provide for an internal driving mechanism (e.g., a small motor communicating with a remote control system), provided herein is a system for driving the device 100 having a magnet 150 as the actuator. Specifically, described herein is a system for driving an arteriovenous fistula device (e.g., device 100) by the use of an external driver 800 with a driver magnet 802.
The first body 812 includes two screw slots 816 extending through the first body 812 towards the second body 814. The screw slots 816 are configured to accept a screw 818 therethrough. The second body 814 includes two fastener slots 820 each configured to accept a nut 822. Thus, the first body 812 is coupled to the second body 814 by placing the nuts 822 in the two fastener slots 820 of the second body 814 and placing the screws 818 in the screw slots 816 of the first body 812. The screws 818 engage with the nuts 822 to secure the housing 810 in place. In some implementations, the screws 818, nuts 822, housing 810, and other components of the external driver 800 are made from plastic or other non-ferrous material so that interference with the driver magnet 802 is avoided.
The external driver 800 includes a driver magnet 802 (e.g., the external magnet 780 from the benchtop prototype). The driver magnet 802 is disposed within a magnet slot 824 of the housing 810. The driver magnet 802 is disposed close to a bottom surface 826 of the housing 810. The external driver 800 further includes a handle 804 coupled to the driver magnet 802 (e.g., via adhesive resin). The handle 804 extends through a top surface 828 of the housing 810 to engage with and/or couple to the driver magnet 802. The driver magnet 802 and the handle 804 include a turning axis or a main axis 830 about which they rotate.
In use, an arteriovenous fistula banding device (e.g., device 100) is implanted within a patient wherein the band 102 of the device 100 wraps around an arteriovenous fistula and defines a central channel 112 within which the arteriovenous fistula is disposed. In order to adjust the diameter of the central channel 112, the magnet 150 can be rotated by the external driver 800. Specifically, rotation of the the magnetic field of the driver magnet 802 external to the patient can drive rotation of the magnet 150 implanted within the patient about the screw axis 155.
The external driver 800 is placed on the patient adjacent to the device 100 wherein the bottom surface 826 of the external driver 800 is adjacent to the patient's skin. The device 100 is easily located because of the attraction between the driver magnet 802 and the magnet 150 of the device 100. Once in place, the handle 804 is rotated (e.g., by a medical professional or by a medical device with a controller attached) which, in turn, rotates the driver magnet 802 about the main axis 830. The rotating magnetic field of the driver magnet 802 causes the magnet 150 to rotate which causes the diameter of the central channel 112 to increase or decrease, depending on the direction of rotation. The direction of the rotation, and resultant size change in the diameter of the central channel 112, may be indicated on the external driver 800 or by some external control system.
Example Driving System #2
The housing 920 of the arteriovenous fistula banding device 903 includes a magnetic screw 940. In contrast to the screw 140 of device 100, the magnetic screw 940 includes a central magnetic core 942 with at least one thread 944 wrapped around it. The magnetic screw 940 is configured to rotate about a screw axis 945. Similar to the device 100, the at least one thread 944 is configured to abut and engage with the magnetic screw 940 to extend or retract the second end 906 of the band 902, which expands or contracts the diameter of the central channel 912. However, in contrast to the teeth of device 100, the at least one thread 944 of the arteriovenous fistula banding device 903 extend through the plurality of slots 914 in the band 902.
The external driver 950 is placed outside of the skin adjacent to the arteriovenous fistula banding device 903. The external driver 950 includes a handle 952 and an external magnet 954. However, while the external driver 800 of the example driving system #1 includes diametrical disc magnets with aligned axes, the external magnet 954 of example driving system #2 includes an external axis 955 which is parallel to and separated apart from the screw axis 945. Thus, by rotating the handle 952 and the external magnet 954 about the external axis 955, the magnetic screw 940 is driven to rotate about the screw axis 945. The rotation of the magnetic screw 940 moves the band 902 to increase or decrease the diameter of the central channel 912.
Example Driving System #3
The device 1001 is similar to device 100 of
For example,
Experimental Device Testing
Tests were performed to ensure proper operation of performance of the devices and systems described herein. For example, device 100 and external driver 800 were manufactured and tested to ensure that the band 102 would expand or contract in response to rotation of the handle 804. One point of testing was the distance between the magnet 150 and the driver magnet 802 to ensure that rotation of the driver magnet 802 would adequately rotate the magnet 150. Such a distance may be the distance between an implanted device 100 and an external driver 800 disposed on a patient's skin adjacent to the device 100.
A testing device 1100 was manufactured, as shown in
The bottom surface 1106 of the testing device 1100 includes a connection rig 1114 including two posts 1116 configured to engage with the suture holes 134 of the device 100 to hold the device 100 in place. The device 100 was placed on the connection rig 1114 via the posts 1116 such that second side 124 of the housing 120 is disposed adjacent to the bottom surface 1106 of the testing device 1100. Thus, the device 100 was “implanted” in the testing device 1100, simulating implanting in a patient.
The external driver 800 was then placed on the top surface 1104 of the testing device 1100. The main axis 830 of the handle 804 and the driver magnet 802 were aligned with the screw axis 155 of the magnet 150 and screw 140 naturally due to the attraction between the magnet 150 and the driver magnet 802. The handle 804 was turned, rotating the driver magnet 802 about the main axis 830. The rotating magnetic field resulted in rotation of the magnet 150 and screw 140 about the screw axis 155. Thus, the at least one thread 142 engaged with the plurality of teeth 114 of the band 102, expanding the diameter of the central channel 112. This test verified the operation of the device 100 with the external driver 800.
Example Method
Described herein are methods for controlling blood flow through an arteriovenous fistula. In one implementation, methods are disclosed for controlling and/or operating an arteriovenous fistula banding device (e.g., device 100) and a corresponding system including an external driver (e.g., external driver 800).
For example,
Next, at step 1202, the method 1200 includes rotating the magnet 150 to cause rotation of the screw 140 such that the at least one thread 142 of the screw 140 contacts a portion of the band 102 to expand or contract the central channel 112 to a second diameter. Such rotation may be accomplished, for example, via an external driver magnet. The external driver magnet may be the driver magnet 802 of the external driver 800 which is disposed outside a patient's body and adjacent to the arteriovenous fistula banding device 100.
The method 1200 then includes, at step 1203, expanding or contracting an inner diameter of the arteriovenous fistula such that a fluid flow rate (e.g., blood flow rate) through the arteriovenous fistula is increased or decreased. Thus, the method 1200 can be implemented to controllably change the blood flow through a patient's arteriovenous fistula. For example, once a device 100 is implanted, the diameter of the fistula may be reduced during normal operation (e.g., a regular day). Then, when the patient receives hemodialysis treatment, the diameter of the fistula is expanded so that the flow rate is increased for the duration of the dialysis treatment. Once dialysis is complete, the fistula is returned to the normal flow rate operation.
Optionally, method 1200 further includes, at step 1204, measuring the fluid flow rate through the central channel 112 via a flow sensor disposed adjacent to the central channel 112 (e.g., the flow sensor 360 in
Optionally, method 1200 further includes, at step 1205, receiving a measured flow rate at a controller (e.g., the controller 370 of
Configuration of Certain Implementations
The construction and arrangement of the systems and methods as shown in the various implementations are illustrative only. Although only a few implementations have been described in detail in this disclosure, many modifications are possible (e.g., variations in sizes, dimensions, structures, shapes, and proportions of the various elements, values of parameters, mounting arrangements, use of materials, colors, orientations, etc.). For example, the position of elements may be reversed or otherwise varied, and the nature or number of discrete elements or positions may be altered or varied. Accordingly, all such modifications are intended to be included within the scope of the present disclosure. The order or sequence of any process or method steps may be varied or re-sequenced according to alternative implementations. Other substitutions, modifications, changes, and omissions may be made in the design, operating conditions, and arrangement of the implementations without departing from the scope of the present disclosure.
The present disclosure contemplates methods, systems, and program products on any machine-readable media for accomplishing various operations. The implementations of the present disclosure may be implemented using existing computer processors, or by a special purpose computer processor for an appropriate system, incorporated for this or another purpose, or by a hardwired system. Implementations within the scope of the present disclosure include program products including machine-readable media for carrying or having machine-executable instructions or data structures stored thereon. Such machine-readable media can be any available media that can be accessed by a general purpose or special purpose computer or other machine with a processor. By way of example, such machine-readable media can comprise RAM, ROM, EPROM, EEPROM, CD-ROM or other optical disk storage, magnetic disk storage or other magnetic storage devices, or any other medium which can be used to carry or store desired program code in the form of machine-executable instructions or data structures, and which can be accessed by a general purpose or special purpose computer or other machine with a processor.
When information is transferred or provided over a network or another communications connection (either hardwired, wireless, or a combination of hardwired or wireless) to a machine, the machine properly views the connection as a machine-readable medium. Thus, any such connection is properly termed a machine-readable medium. Combinations of the above are also included within the scope of machine-readable media. Machine-executable instructions include, for example, instructions and data which cause a general-purpose computer, special purpose computer, or special purpose processing machines to perform a certain function or group of functions.
Although the figures show a specific order of method steps, the order of the steps may differ from what is depicted. Also, two or more steps may be performed concurrently or with partial concurrence. Such variation will depend on the software and hardware systems chosen and on designer choice. All such variations are within the scope of the disclosure. Likewise, software implementations could be accomplished with standard programming techniques with rule-based logic and other logic to accomplish the various connection steps, processing steps, comparison steps and decision steps.
It is to be understood that the methods and systems are not limited to specific synthetic methods, specific components, or to particular compositions. It is also to be understood that the terminology used herein is for the purpose of describing particular implementations only and is not intended to be limiting.
As used in the specification and the appended claims, the singular forms “a,” “an” and “the” include plural referents unless the context clearly dictates otherwise. Ranges may be expressed herein as from “about” one particular value, and/or to “about” another particular value. When such a range is expressed, another implementation includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value forms another implementation. It will be further understood that the endpoints of each of the ranges are significant both in relation to the other endpoint, and independently of the other endpoint.
“Optional” or “optionally” means that the subsequently described event or circumstance may or may not occur, and that the description includes instances where said event or circumstance occurs and instances where it does not.
Throughout the description and claims of this specification, the word “comprise” and variations of the word, such as “comprising” and “comprises,” means “including but not limited to,” and is not intended to exclude, for example, other additives, components, integers or steps. “Exemplary” means “an example of” and is not intended to convey an indication of a preferred or ideal implementation. “Such as” is not used in a restrictive sense, but for explanatory purposes.
Disclosed are components that can be used to perform the disclosed methods and systems. These and other components are disclosed herein, and it is understood that when combinations, subsets, interactions, groups, etc. of these components are disclosed that while specific reference of each various individual and collective combinations and permutation of these may not be explicitly disclosed, each is specifically contemplated and described herein, for all methods and systems. This applies to all aspects of this application including, but not limited to, steps in disclosed methods. Thus, if there are a variety of additional steps that can be performed it is understood that each of these additional steps can be performed with any specific implementation or combination of implementations of the disclosed methods.
This application is a continuation of U.S. Patent Application No. 63/346,086, filed May 26, 2022, which is incorporated herein by reference in its entirety.
Number | Date | Country | |
---|---|---|---|
63346086 | May 2022 | US |